Meridian Bioscience Provides FY 2013 Guidance | GenomeWeb

NEW YORK (GenomeWeb News) - Meridian Bioscience today provided financial guidance for fiscal-year 2013 and reaffirmed its 2012 guidance given just a month ago.

The Cincinnati-based diagnostics firm said that it expects revenues for its fiscal year ended Sept. 30, 2013, to be in the range of $190 million to $195 million. It also anticipates per-share diluted earnings to be between $.86 and $.91.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

HHS Secretary Tom Price says the NIH budget contains unneeded expenses that can be trimmed, Stat News reports.

The chair of the House science committee says the journal Science is not objective, the Huffington Post reports.

In Nature this week: glioma GWAS uncovers new risk loci, and more.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.